- Home
- / Aziyo
Aziyo
Stock Price
$1.4
2023-11-06
Market Capitalization
$24.2 M
2023-11-06
Revenue
$12.3 M
FY, 2025
Aziyo Summary
Company Summary
- Overview
- Aziyo Biologics is a regenerative medicine company focused on the development and commercialization of products in orthopedic, cardiovascular, and other medical specialties. It specializes in cardiac device envelope, vascular surgery, cardiothoracic repair, orthopedics and spine sports medicine, etc.
- Type
- Public
- Status
- Active
- Founded
- 2015
- HQ
- Silver Spring, MD, US | view all locations
- Website
- http://www.aziyo.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Jeff Hamet, VP, Finance
Matthew Ferguson, Chief Financial Officer
Ron Lloyd, President, CEO & Board Member
Operating MetricsView all
Product Brands
9
Q2, 2020
Direct Sales Representatives
27
Q2, 2020
Medical Institutions Covered
1.2K
Oct, 2020
LocationsView all
3 locations detected
Silver Spring, MD HQ
United States
12510 Prosperity Dr #370
Richmond, CA
United States
880 Harbour Way S #100
Roswell, GA
United States
1100 Old Ellis Rd #1200
Aziyo Financials
Summary Financials
- Revenue (Q1, 2026)
- $3.1M
- Gross profit (Q1, 2026)
- $1.8M
- Net income (Q1, 2026)
- ($7.5M)
- Cash (Q1, 2026)
- $28.5M
- EBIT (Q1, 2026)
- ($6.3M)
- Enterprise value
- ($580.8K)